PDF herunterladen
Synlett 2012; 23(18): 2603-2608
DOI: 10.1055/s-0032-1317329
letter
© Georg Thieme Verlag Stuttgart · New York

Transition-Metal-Catalyzed Arylation of 1-Deazapurines via C–H Bond Activation

Viktor O. Iaroshenko*
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   eMail: viktor.iaroshenko@uni-rostock.de   eMail: iva108@googlemail.com
b   National Taras Shevchenko University, 62 Volodymyrska st., Kyiv-33, 01033, Ukraine
,
Iftikhar Ali
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   eMail: viktor.iaroshenko@uni-rostock.de   eMail: iva108@googlemail.com
,
Satenik Mkrtchyan
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   eMail: viktor.iaroshenko@uni-rostock.de   eMail: iva108@googlemail.com
,
Volodymyr Semeniuchenko
b   National Taras Shevchenko University, 62 Volodymyrska st., Kyiv-33, 01033, Ukraine
,
Dmytro Ostrovskyi
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   eMail: viktor.iaroshenko@uni-rostock.de   eMail: iva108@googlemail.com
,
Peter Langer
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   eMail: viktor.iaroshenko@uni-rostock.de   eMail: iva108@googlemail.com
c   Leibniz-Institut für Katalyse e. V. an der Universität Rostock, Albert-Einstein-Str. 29a, 18059 Rostock, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 02. August 2012

Accepted after revision: 06. September 2012

Publikationsdatum:
01. Oktober 2012 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik


Abstract

Transition-metal-catalyzed arylation of imidazo[4,5-b]pyridines (known as 1-deazapurines) is reported. 1-Deazapurines were synthesized from 5-aminoimidazoles, generated in situ by the reaction of methyl N-(cyanomethyl)formimidate with primary amines.

Key words

catalysis - nickel - C–H activation - arylation - 1-deazapurine - imidazole

Supporting Information

    for this article is available online at http://www.thieme-connect.com/ejournals/toc/synlett.
  • Supporting Information
 

  • References

  • 2 Joseph EC, Rees JA, Dayan AD. Toxicol. Pathology 1996; 24: 436
    Suche in Google Scholar
  • 3 Ida K, Otsubo N, Kuboyama T, Arai H, Watanabe A, Saki M, Hiura N, Manabe H, Tekada H, Saito J. WO2005082905, 2005 ; Chem. Abstr. 2005, 143, 266925
    • 4a Bavetsias V, Sun C, Bouloc N, Reynisson J, Workman P, Linardopoulos S, McDonald E. Bioorg. Med. Chem. Lett. 2007; 17: 6567
      CrossrefPubMedSuche in Google Scholar
    • 4b Chan F, Sun C, Perumal M, Nguyen Q.-D, Bavetsias V, McDonald E, Martins V, Wilsher NE, Raynaud MValenti S, Eccles R, te Poele P, Workman FI, Aboagye EO, Linardopoulos S. Mol. Cancer Ther. 2007; 6: 3147
      CrossrefSuche in Google Scholar
    • 5a Rizzo M, Ventrice D, Monforte F, Procopio S, De Sarro G, Anzini M, Cappelli A, Makovec F. J. Pharm. Biomed. Anal. 2004; 35: 321
      CrossrefSuche in Google Scholar
    • 5b Rizzo M, Anzini M, Cappelli A, Vomero S, Ventrice D, De Sarro G, Procopio S, Costa N, Makovec F. Farmaco 2003; 58: 837
      CrossrefSuche in Google Scholar
    • 5c Casimiro-Garcia A, Filzen GF, Flynn D, Bigge CF, Chen J, Davis JA, Dudley DA, Edmunds JJ, Esmaeil N, Geyer A, Heemstra RJ, Jalaie M, Ohren JF, Ostroski R, Ellis T, Schaum RP, Stoner C. J. Med. Chem. 2011; 54: 4219
      CrossrefSuche in Google Scholar
    • 5d Wexler RR, Greenlee WJ, Irvin JD, Goldberg MR, Prendergast K, Smith RD, Timmermans PB. M. W. M. J. Med. Chem. 1996; 39: 625
      CrossrefSuche in Google Scholar
    • 5e Mantlo NB, Chakravarty PK, Ondeyka DL, Siegl PK. S, Chang RS, Lotti VJ, Faust KA, Schorn TW, Chen TB. J. Med. Chem. 1991; 34: 2919
      CrossrefSuche in Google Scholar
    • 5f Kim D, Mantlo NB, Chang RS. L, Kivlighn SD, Greenlee WJ. Bioorg. Med. Chem. Lett. 1994; 4: 41
      CrossrefSuche in Google Scholar
    • 5g Mantlo NB, Chang RS. L, Siegl PK. S. Bioorg. Med. Chem. Lett. 1993; 3: 1693
      CrossrefSuche in Google Scholar
    • 6a Cristalli G, Vittori S, Eleuteri A, Grifantini M, Volpini R, Lupidi G, Capolongo L, Pesenti E. J. Med. Chem. 1991; 34: 2226
      CrossrefSuche in Google Scholar
    • 6b Bergman AM, Cristalli G, Vittori S, Wang J, Eriksson S, Peters G. Nucleosides Nucleotides 1999; 18: 897
      Suche in Google Scholar
  • 7 Bennett LJr, Smithers D, Rose LM, Adamson DJ, Brockman RW. Biochem. Pharmacol. 1984; 33: 261
    CrossrefSuche in Google Scholar
  • 8 Clark RL, Pessolano AA, Shen T.-Y, Jacobus DP, Jones H, Lotti VJ, Flataker LM. J. Med. Chem. 1978; 21: 965
    CrossrefSuche in Google Scholar
    • 9a Hocková D, Hocek M, Dvoráková H, Votruba I. Tetrahedron 1999; 55: 11109
      CrossrefSuche in Google Scholar
    • 9b Kuczynski L, Mrozikiewicz A, Poreba K. Pol. J. Pharmacol. Pharm. 1982; 34: 229
      Suche in Google Scholar
    • 9c Bianchi M, Butti A, Rossi S, Barzaghi F, Marcaria V. Eur. J. Med. Chem. 1983; 18: 501
      Suche in Google Scholar
    • 9d Ostrovskyi D, Iaroshenko VO, Ali I, Mkrtchyan S, Villinger A, Tolmachev A, Langer P. Synthesis 2011; 133 ; and references therein
      Thieme Connect
  • 11 Burnstock G. Nat. Rev. Drug Discovery 2008; 7: 575
    CrossrefSuche in Google Scholar
  • 12 Chu CK. Recent Advances in Nucleosides: Chemistry and Chemotherapy. Elsevier; Amsterdam: 2002
    Suche in Google Scholar
    • 16a Iaroshenko VO, Mkrtchyan S, Gevorgyan A, Vilches-Herrera M, Sevenard DV, Villinger AT, Ghochikyan V, Saghiyan A, Sosnovskikh VY, Langer P. Tetrahedron 2012; 68: 2532
      CrossrefSuche in Google Scholar
    • 16b Iaroshenko VO, Mkrtchyan S, Ghazaryan G, Hakobyan A, Maalik A, Supe L, Villinger A, Tolmachev A, Ostrovskyi D, Sosnovskikh VY, Ghochikyan TV, Langer P. Synthesis 2011; 469
      Thieme Connect
    • 16c Iaroshenko VO, Ostrovskyi D, Petrosyan A, Mkrtchyan S, Villinger A, Langer P. J. Org. Chem. 2011; 76: 2899
      CrossrefSuche in Google Scholar
    • 16d Iaroshenko VO, Sevenard DV, Kotljarov A, Volochnyuk DM, Tolmachev AO, Sosnovskikh VY. Synthesis 2009; 731
      Thieme Connect
    • 16e Iaroshenko VO, Specowius V, Vlach K, Vilches-Herrera M, Ostrovskyi D, Mkrtchyan S, Villinger A, Langer P. Tetrahedron 2011; 67: 5663
      CrossrefSuche in Google Scholar
    • 16f Ostrovskyi D, Iaroshenko VO, Petrosyan A, Dudkin S, Ali I, Villinger A, Tolmachev A, Langer P. Synlett 2010; 2299
      Thieme Connect
  • 19 Ozden S, Ozden T, Gumus F, Akin S. Ankara Universitesi Eczacilik Fakultesi Dergisi 1985; 15: 79 ; Chem. Abstr. 1988, 108, 112330
    Suche in Google Scholar
  • 20 Seregin IV, Gevorgyan V. Chem. Soc. Rev. 2007; 36: 1173
    Suche in Google Scholar
  • 26 Iaroshenko VO, Ostrovskyi D, Milyutina M, Maalik A, Villinger A, Tolmachev A, Volochnyuk DM, Langer P. Adv. Synth. Catal. 2012; 2495
  • 27 General Procedure for the Synthesis of Compounds 6a-n Using Cu and Pd Catalyst: DMF (8 mL) was added to an argon-purged pressure tube containing 3H-imidazo[4,5-b]pyridine 5a–h (1 mmol), Pd(OAc)2 (0.05 mmol, 5 mol%), CuI (3 mmol), ArX (2 mmol), and Cs2CO3 (2.5 mmol). The reaction mixture was stirred at 150 °C for 30–60 h. After cooling to r.t., the solvent was evaporated under reduced pressure and the products were isolated and purified by column chromatography (gradient elution n-heptane–EtOAc, EtOAc–i-PrOH)
  • 28 3-Phenethyl-2-phenyl-5-(thiophen-2-yl)-7-(trifluoromethyl)-3H-imidazo[4,5-b]pyridine (6i): Bright-yellow solid; mp 137–139 °C; 1H NMR (300.13 MHz, CDCl3): δ = 3.14 (t, J = 6.99, 2 H, CH2), 4.57 (t, J = 7.55, 2 H, CH2), 6.99 (d, J = 8.12 Hz, 2 H, ArH), 7.12–7.16 (m, 2 H, ArH), 7.28–7.44 (m, 5 H, ArH), 7.51–7.59 (m, 2 H, ArH), 7.63 (d, J = 7.18 Hz, 2 H, ArH), 7.76 (s, 1 H, ArH); 13C NMR (62.89 MHz, CDCl3): δ = 35.6 (CH2), 45.6 (CH2), 110.3 (q, 3 J C–F = 4.12 Hz, CH), 122.8 (q, 1 J C–F = 274.00 Hz, CF3), 124.2 (CH), 125.8 (2CH), 126.0 (CH), 126.9 (CH), 127.9 (CH), 128.3 (q, 2 J C–F = 33.88 Hz, C), 128.7 (CH), 128.8 (3CH), 129.0 (CH), 129.3 (CH), 129.5 (C), 130.4 (CH), 134.2 (C), 137.4 (C), 143.4 (C), 146.6 (C), 149.8 (C), 156.5 (C); 19F NMR (282.40 MHz, CDCl3): δ = –61.99 (ArCF3); IR (ATR): 3025 (w), 2960 (s), 2927 (m), 2868 (w), 1907 (w), 1732 (w), 1600 (m), 1544 (m), 1496 (m), 1467 (w), 1453 (w), 1443 (w), 1418 (w), 1384 (s), 1367 (w), 1339 (w), 1329 (w), 1309 (w), 1271 (m), 1250 (m), 1228 (w), 1155 (w), 1125 (s), 1099 (w), 1073 (w), 1049 (w), 1029 (w), 1020 (w), 1004 (w), 959 (w), 942 (w), 929 (w), 898 (w), 868 (m), 846 (w), 833 (w), 809 (s), 779 (w), 755 (m), 739 (w), 696 (w), 684 (m), 666 (w), 618 (w), 609 (w), 586 (w), 558 (m), 532 (w) cm–1; GC-MS (EI, 70 eV): m/z (%) = 449 (26) [M]+, 358 (2), 345 (100), 324 (1), 242 (1), 208 (2), 186 (1), 146 (1), 105 (1), 91 (1), 77 (2); HRMS (ESI): m/z [M + H]+ calcd for C25H19F3N3S: 450.12463; found: 450.12452
  • 30 General Procedure for the Synthesis of Compounds 6a–n Using Ni Catalyst: DMF (8 mL) was added to an argon-purged pressure tube containing 3H-imidazo[4,5-b]pyridine 5a–h (1 mmol), [NiCl2(PPh3)2] (0.05 mmol, 5 mol%), ArX (2 mmol), and K2CO3 (2.5 mmol). The reaction mixture was stirred at 110 °C for 15 h. After cooling to r.t., the solvent was evaporated under reduced pressure and the products were isolated and purified by column chromatography (gradient elution n-heptane–EtOAc, EtOAc–i-PrOH)
  • 31 Hegedus LS In Organometallics in Synthesis . Schlosser M. John Wiley and Sons; Chichester: 2002: 1123-1217
    Suche in Google Scholar
  • 32 Pintori DG, Greaney MF. J. Am. Chem. Soc. 2011; 133: 1209
    CrossrefPubMedSuche in Google Scholar
  • 33 Huang J, Chan J, Chen Y, Borths CJ, Baucom KD, Larsen RD, Faul MM. J. Am. Chem. Soc. 2010; 132: 3674
    CrossrefSuche in Google Scholar
    • 34a Schareina T, Zapf A, Mägerlein W, Müller N, Beller M. Synlett 2007; 555
    • 34b Schareina T, Zapf A, Mägerlein W, Müller N, Beller M. Chem.–Eur. J. 2007; 13: 6249
      Suche in Google Scholar